2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
No abstract available

Keywords: DOACs; NOACs; apixaban; dabigatran; edoxaban; rivaroxaban.

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Dabigatran / therapeutic use
  • Humans
  • Pyridones / therapeutic use
  • Rivaroxaban / therapeutic use
  • Stroke* / diagnosis
  • Stroke* / etiology
  • Stroke* / prevention & control

Substances

  • Anticoagulants
  • Pyridones
  • Rivaroxaban
  • Dabigatran